1. Bischof Delaloye A, Carrió I, Cuocolo A, Knapp W, Gourtsoyiannis N, McCall I, et al. White paper of the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) on multimodality imaging. Eur J Nucl Med Mol Imaging 2007;34(8):1147–51.
2. Israel O. Indications, results and pitfalls of PETCT in posttreatment follow-up of lung cancer and H&N cancer. Eur J Nucl Med Mol Imaging 2009;36 Suppl 2:OP211.
3. Shirvan A, Allen A, Steinmetz A, Reshef A, Akselrod A, Hoglund J, et al. Apoptosis imaging in clinical trials: dynamic PET studies with 18F-ML-10. Eur J Nucl Med Mol Imaging 2009;36 Suppl 2:OP296.
4. Yamane T, Sakamoto S, Senda M. Clinical impact of C-11 methionine PET on expected management of patients with brain neoplasm. Eur J Nucl Med Mol Imaging 2009;36 Suppl 2:P077.
5. Toubaru S, Yoshikawa K, Ohashi S, Hasebe M, Ishikawa H, Sagou K, et al. Usefulness of C-11 methionine PET/CT for predicting recurrence, metastasis and prognosis of patients with lung cancer treated by carbon ion radiotherapy. Eur J Nucl Med Mol Imaging 2009;36 Suppl 2:P116.